RAN pseudogene 6 (RANP6)

RAN pseudogene 6 (RANP6) is designated as a pseudogene related to the *RAN* (ras-related nuclear protein) gene, but does not encode a functional protein and is not considered a druggable therapeutic target. Pseudogenes arise through gene duplication or retrotransposition events and typically harbor mutations (frameshifts, premature stop codons) that prevent them from producing a full-length, functional protein. While some pseudogenes can exert regulatory effects, for example as competing endogenous RNAs (ceRNAs), acting as "sponges" for microRNAs, no specific functional or disease associations are reported for RANP6. In molecular and clinical databases, RANP6 is not listed as a receptor, enzyme, transporter, or other pharmacologically relevant target, and thus should not be considered a canonical target for drug development. Key points: - RANP6 is properly classified as a pseudogene, not a protein-coding gene or receptor. - There is no credible evidence that RANP6 encodes a protein, interacts with drugs, or has established utility as a biomarker or therapeutic target. Pseudogenes are referenced in genomic annotation largely for completeness, and can occasionally be a source of assay interference or regulatory RNA species. - The canonical functional gene is **RAN ("ras-related nuclear protein")**, which is a small GTPase involved in nuclear transport, cell cycle, and microtubule regulation. Is there something wrong with the target? Yes: "RAN pseudogene 6" is *not* a target in the traditional sense (receptor, enzyme, etc.) and lacks documented biological or pharmacological relevance. Use caution when encountering targets named as "pseudogene [number]" unless there is strong supporting literature or database evidence. If you need structured information on **RAN** itself (the protein-coding gene), that should be requested and is substantially different.

Other names

RANP6RAN pseudogene 6